<DOC>
	<DOC>NCT02661438</DOC>
	<brief_summary>The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.</brief_summary>
	<brief_title>Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Inclusion Criteria Subjects (male and female) with noncystic fibrosis bronchiectasis (NCFB) or chronic obstructive pulmonary disease (COPD) Subjects must be aged â‰¥40 Subject must be able to independently manage and administer their NCFB/COPD medications Subjects with recent exacerbation Subjects with recent significant hemoptysis in the four weeks before screening (and/or during the screening period) Subjects allergic to quinine Known chronic bronchial asthma</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Usability Test</keyword>
</DOC>